UK markets open in 6 hours 4 minutes

Myriad Genetics, Inc. (0K3W.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
18.00-0.65 (-3.49%)
At close: 02:41PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.98
52-week change 3-7.62%
S&P500 52-week change 322.64%
52-week high 324.13
52-week low 30.00
50-day moving average 320.63
200-day moving average 320.78

Share statistics

Avg vol (3-month) 3237
Avg vol (10-day) 3238
Shares outstanding 574.76M
Implied shares outstanding 6N/A
Float 874.82M
% held by insiders 12.35%
% held by institutions 1102.40%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -34.96%
Operating margin (ttm)-12.56%

Management effectiveness

Return on assets (ttm)-7.40%
Return on equity (ttm)-31.55%

Income statement

Revenue (ttm)753.2M
Revenue per share (ttm)9.10
Quarterly revenue growth (yoy)10.60%
Gross profit (ttm)N/A
EBITDA -82.7M
Net income avi to common (ttm)-263.3M
Diluted EPS (ttm)-0.11
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)140.9M
Total cash per share (mrq)1.57
Total debt (mrq)152.1M
Total debt/equity (mrq)19.42%
Current ratio (mrq)2.01
Book value per share (mrq)8.71

Cash flow statement

Operating cash flow (ttm)-110.9M
Levered free cash flow (ttm)-61.42M